吉非替尼初治有效的非小细胞肺癌进展后吉非替尼再治疗的疗效评估
评价者:赵明芳1, 文献合成者:何燕燕2

Assessment of Retreatment of Gefitinib in Patients with Non-Small-Cell Lung Cancer Who Previously Controlled to Gefitinib
Reviewer:ZHAO Ming-fang1, Literature Co-worker: HE Yan-yan2
图 1 TKI 获得性耐药机制频率